□ The Daegu Gyeongbuk Institute of Science & Technology (DGIST; President Kunwoo Lee) announced that Professor Cheolgi Kim of the Department of Physics and Chemistry has been selected by the National Academy of Medicine of Korea as a new full member for 2026.
□ The National Academy of Medicine of Korea, which selects full members based on a comprehensive evaluation of academic achievements and social contributions,is one of the most prestigious academic societies in Korea. In 2026, it selected 63 new full members: 59 medical professionals and 4 researchers in medical physics and medical engineering.
□ Medical physics and medical engineering researcher Professor Cheolgi Kim, who was selected as a new full member, is noted for his research on developing biochips and non-invasive medical devices based on magnetic technology. He has also suggested technology that enables more precise diagnoses of diseases and evaluations of patients’ conditions. As it allows for simultaneously conducting repeated measurements and highly precise analyses, magnetic-based technology is considered the next-generation medical technology that overcomes the limitations of traditional testing methods.
□ This study’s findings have also been expanded to industrial applications. Nature Environment & Technology (Nature E&T), a healthcare tech company, is working with DGIST researchers to commercialize magnetic-based diagnostic and treatment devices, and has decided to invest in LMNTIC-Bio, a biotech company founded based on DGIST sensor technology. On the basis of this development, they accelerate the commercialization of research findings into practice and applications in the medical device industry.
□ “Together with Nature Environment & Technology, we plan to conduct clinical collaborative research with overseas medical institutions, including the University Hospital of Montpellier in France and Phenikaa University Hospital in Vietnam, to demonstrate the clinical effectiveness of magnetic technology–based medical devices internationally, and to consider entering the global medical market in stages,” said Professor Cheolgi Kim.
□ Meanwhile, DGIST will continue to expand research combining medicine and engineering, thereby contributing to the development and industrialization of future medical technology.
